Posted on 9/29/20
Team Gleason Donates $750,000 To Expand Boston Children’s Hospital’s ALS Augmentative Communication Program
NEW ORLEANS & BOSTON--(BUSINESS WIRE)--Team Gleason, a leading foundation for ALS patient support, is collaborating with Boston Children’s Hospital’s ALS Augmentative Communication Program, which provides expert . . .
Posted on 9/28/20
Beam Therapeutics Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines though base-editing, announced today the commencement . . .
Posted on 9/28/20
Fierce Biotech Names Amylyx Pharmaceuticals as One of Its “Fierce 15” Biotech Companies of 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced . . .
Posted on 9/28/20
Carmine Therapeutics Named as One of FierceBiotech's "Fierce 15" Biotech Companies of 2020
Carmine Therapeutics announced today that it has been named by FierceBiotech as one of 2020's Fierce 15 biotechnology companies, designating it as one of the most . . .
Posted on 9/28/20
Fierce Biotech Names ROME Therapeutics as One of its “Fierce 15” Biotech Companies of 2020
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ROME Therapeutics, a biotechnology company harnessing the power of the repeatome in drug development, today announced that it has been named by Fierce Biotech . . .
Posted on 9/28/20
Here's the Bigger Story About Moderna That You Might Be Missing
Ask most people about Moderna (NASDAQ:MRNA) and you're likely to get one of two responses. Many individuals won't recognize the company's name at all. Of those . . .
Posted on 9/27/20
Radius Health Provides Business Update
WALTHAM, Mass., (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jose (Pepe) Carmona will be stepping down as Chief Financial Officer of Radius . . .
Posted on 9/27/20
Dyne Therapeutics Closes IPO
WALTHAM, Mass., (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases, . . .
Posted on 9/23/20
Wave Life Sciences Prices $100 Million Public Offering
CAMBRIDGE, Mass., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people . . .
Posted on 9/23/20
Arch Therapeutics' AC5 Heals Recalcitrant Diabetic Foot Ulcer
SummaryArch Therapeutics has FDA and EMA approval for AC5.They are seeding Key Opinion Leaders to get real-world case reports.They just reported the first case in diabetic . . .
Posted on 9/22/20
MellingMedical Partners with Lions VisionGift
Today, MellingMedical, a leading supplier of medical supplies, equipment, devices and pharmaceuticals nationwide, announced their partnership with Lions VisionGift to provide corneal tissue to the Olin . . .
Posted on 9/21/20
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
All eyes are on Moderna's (NASDAQ:MRNA) coronavirus vaccine, but the biotech is looking ahead, setting up a new research collaboration with Vertex Pharmaceuticals (NASDAQ:VRTX) to develop . . .
Posted on 9/21/20
Moderna Plans to Produce 20 Million Doses of Its COVID-19 Vaccine Candidate in 2020
As the phase 3 clinical trial of Moderna's (NASDAQ:MRNA) COVID-19 vaccine candidate continues, the company on Friday said it expects to produce 20 million doses of . . .
Posted on 9/21/20
Better Coronavirus Stock: AstraZeneca or Moderna?
Only three coronavirus vaccine candidates with the potential to be marketed in the U.S. are currently in late-stage testing. AstraZeneca (NYSE:AZN) and Moderna (NASDAQ:MRNA) claim two . . .
Posted on 9/22/20
Henry Mortimer, citybiz Editor-at-Large, Interview with Mark Olcott, CEO of VitusVet
Helping Veterinarians Run Their Practices More Efficiently — and Making Pets Healthier By Henry Mortimer, citybiz Editor-at-Large Any breakdown in communication can jeopardize the important relationship between . . .
Posted on 9/18/20
424 Capital Investment in Hospital Energy
424 Capital announced today that it has launched its first new fund in the 424 series, 424 Capital Fund I, which simultaneously completed the acquisition of . . .
Posted on 9/18/20
Bristol-Myers Squibb Cuts Deal, Delaying Threat to Top-Selling Revlimid
Bristol-Myers Squibb (NYSE:BMY) is granting Dr. Reddy's Laboratories (NYSE:RDY) a volume-limited license to produce a generic version of its blockbuster multiple myeloma drug, Revlimid, beginning in . . .
Posted on 9/18/20
Eaton Vance Corp.: Steadily Building Wealth
SummaryA diversified asset management firm across funds and strategies.Steady growth in assets under management and earnings.Mixed results in fund performance.I do much more than just articles . . .
Posted on 9/18/20
Paratek Pharmaceuticals: Undervalued Antibiotics Play With A Fighting Chance
SummaryParatek has developed 2 antibiotics treatments - Nuzyra and Seysara - to treat different types of skin conditions.The company out-licenses Seysara marketing & sales but has . . .
Posted on 9/18/20
Why Moderna Was So Volatile on Thursday
What happenedModerna (NASDAQ:MRNA) was a roller-coaster stock on Thursday, at one point trading 3% higher, then as much as 6% lower, before settling in for a . . .
Posted on 9/18/20
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
All eyes are on Moderna's (NASDAQ:MRNA) coronavirus vaccine, but the biotech is looking ahead, setting up a new research collaboration with Vertex Pharmaceuticals (NASDAQ:VRTX) to develop . . .
Posted on 9/20/20
Melina Sánchez Montañés, Impact First Investments, Interview with Irad Eichler, CEO at 7Chairs
Irad Eichler is a social entrepreneur who co-founded 7Chairs in 2019. 7Chairs is a teletherapy startup focused on providing emotional support to everyone who is dealing with . . .
Posted on 9/17/20
Finch Therapeutics Announces $90 Million Financing
Finch Therapeutics Group, Inc., a clinical-stage microbiome drug development company, announced today a $90 million Series D financing. New investors in the round include Baupost Group
Posted on 9/17/20
Moderna, Inc.: All Signs Point To An Impending Rally
SummaryModerna’s COVID-19 vaccine candidate, a frontrunner to win the FDA emergency use authorization, is ahead of an interim data readout.After a sharp sell-off over the past . . .
Posted on 9/17/20
Moderna Opens Its First Commercial Office in Europe
In part to increase the potential market reach of its COVID-19 vaccine candidate, Moderna (NASDAQ:MRNA) is opening its first commercial hub outside the United States. The . . .
Boston
